The FINANCIAL -- Through the expansion of the Better Life Farming Alliance to Bangladesh and Indonesia, Bayer and its partners will provide more smallholders with better access to innovative and sustainable agricultural solutions, and increased farm incomes / In 2021, the “Better
More
The FINANCIAL — BlockApps, the leading enterprise blockchain platform provider, today announced the launch of the TraceHarvest Network which is transforming the way agricultural products are managed. The new blockchain-powered business network was developed in collaboration with Bayer, the leading technology innovator in the agriculture industry,
More
The FINANCIAL — Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully completed a USD 65 million Series A financing round and emerged from stealth mode today. The Series A round was led by Leaps by
More
The FINANCIAL — Bayer announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) seeking approval of finerenone for patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). Finerenone is
More
The FINANCIAL — Bayer reported third quarter financial results. Highlights Group sales decrease by 5.1 percent (Fx & portfolio adj.) to 8.506 billion euros / EBITDA before special items falls 21.4 percent to 1.795 billion euros / Substantial decline in sales and
More
The FINANCIAL — Bayer launches its first Global Creative Council. This global initiative brings together senior leaders from a variety of companies representing strategic agencies as well as industry brands. The Council aims to harness progressive and collective creativity of industry marketing
More
The FINANCIAL — Bayer AG today announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in the research, development and manufacturing of gene therapies across different therapeutic areas. AskBio’s development portfolio includes investigational pre-clinical and clinical stage candidates
More
The FINANCIAL– Leaps by Bayer, the impact investment arm of Bayer AG, today announced a USD 8 million financial investment in US-based clinical-stage medical dermatology biotech company Azitra Inc. The partnership will focus on developing cutting-edge skin products using engineered and wild-type bacteria for
More
The FINANCIAL — Despite the challenges posed by Covid-19, Bayer confirms significant progress on its sustainability commitments / Highly innovative carbon initiatives are redefining the value of farming by rewarding farmers for generating carbon credits when adopting climate-smart practices / Game-changing launch
More